BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2769 related articles for article (PubMed ID: 23142087)

  • 1. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
    Nazik H; Ongen B; Ilktac M; Aydin S; Kuvat N; Sahin A; Yemisen M; Mete B; Durmus MS; Balkan II; Yildiz I; Ergul Y
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1178-85. PubMed ID: 23431824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland.
    Poirel L; Schrenzel J; Cherkaoui A; Bernabeu S; Renzi G; Nordmann P
    J Antimicrob Chemother; 2011 Aug; 66(8):1730-3. PubMed ID: 21628303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
    Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
    Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
    Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
    J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P; Garzón D; Mattar S
    Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.
    Feizabadi MM; Delfani S; Raji N; Majnooni A; Aligholi M; Shahcheraghi F; Parvin M; Yadegarinia D
    Microb Drug Resist; 2010 Mar; 16(1):49-53. PubMed ID: 19961397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong.
    Ho PL; Cheung YY; Wang Y; Lo WU; Lai EL; Chow KH; Cheng VC
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):379-85. PubMed ID: 26740321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
    Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
    J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterisation of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. isolates at a tertiary-care centre in Lebanon.
    Kanj SS; Corkill JE; Kanafani ZA; Araj GF; Hart CA; Jaafar R; Matar GM
    Clin Microbiol Infect; 2008 May; 14(5):501-4. PubMed ID: 18325038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
    Jaskulski MR; Medeiros BC; Borges JV; Zalewsky R; Fonseca ME; Marinowic DR; Rocha MP; Nodari P; Machado DC
    Int J Antimicrob Agents; 2013 Jul; 42(1):76-9. PubMed ID: 23664677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey.
    Kilic A; Aktas Z; Bedir O; Gumral R; Bulut Y; Stratton C; Tang YW; Basustaoglu AC
    Ann Clin Lab Sci; 2011; 41(2):161-6. PubMed ID: 21844575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain.
    Curiao T; Morosini MI; Ruiz-Garbajosa P; Robustillo A; Baquero F; Coque TM; Cantón R
    J Antimicrob Chemother; 2010 Aug; 65(8):1608-14. PubMed ID: 20513703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 139.